Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Modest Human Weight Loss (Phase 2 Data) Evidence quality: Moderate (one phase 2b trial, 300 patients) In a 12-week, randomized, double-blind, placebo-controlled trial with 300 obese adults across five sites, oral AOD-9604 produced measurable but modest weight loss
Injectable effects are typically local: redness, mild swelling, or a slight blue-tinted bruise from the copper complex
Zhuravliova, E
Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors
US$ 23.53
US$ 28.89
US$ 23.95
US$ 24.40
US$ 23.00
